Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.

International journal of molecular sciences - 28 May 2024

Galant Natalia, Krawczyk Paweł, Monist Marta, Obara Adrian, Gajek Łukasz, Grenda Anna, Nicoś Marcin, Kalinka Ewa, Milanowski Janusz

Abstract excerpt

Endometrial cancer (EC) accounts for 90% of uterine cancer cases. It is considered not only one of the most common gynecological malignancies but also one of the most frequent cancers among women overall. Nowadays, the differentiation of EC subtypes is based on immunohistochemistry and molecular techniques. It is considered that patients' prognosis and the implementation of the appropriate treatment depend on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Immunotherapy

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 38892080
DOI: 10.3390/ijms25115893
PMCID: PMC11172295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.PMID 38892080Read ↗

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read ↗

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancerSemantic proximity Read ↗

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

[Thoughts on the molecular characteristics of endometrial cancer in clinical diagnosis and treatment].Semantic proximity Read ↗

[Molecular classification of endometrial carcinoma-a short summary for clinical use].Semantic proximity Read ↗

Molecular typing guiding treatment and prognosis of endometrial cancerSemantic proximity Read ↗

Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target TherapySemantic proximity Read ↗

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read ↗

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read ↗

Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies.Semantic proximity Read ↗

Molecular classification of endometrial carcinoma, is it the new era of precision medicine?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.